Patent ID: 11925631
Assignee: GILEAD SCIENCES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 22:
23. The method of claim 22, wherein each R9 is independently:
i) halogen,
ii) —NH2,
iii) —NH(C1-3 alkyl),
iv) —N(C1-3 alkyl)2, wherein each C1-3 alkyl is the same or different,
v) C1-3 alkyl optionally substituted with 1-3 groups independently selected from —OH and halogen,
vi) —OCH3 optionally substituted with 1-3 halogen groups, or
vii) —C(O)N(R19)2, and
each R19 is independently
i) H,
ii) —S(O)2C1-6 alkyl,
iii) C1-6 alkyl optionally substituted with 1-6 groups independently selected from —CN, —OH, halogen, C1-3 alkoxy, and C3-7 monocyclic cycloalkyl,
iv) C3-7 monocyclic cycloalkyl optionally substituted with 1-6 groups independently selected from —CN, —OH, halogen, C1-6 alkyl, and C1-6 alkoxy, wherein the C1-6 alkyl is optionally substituted with 1-3 groups independently selected from —CN, —OH, halogen, and C1-3 alkoxy, or
v) 4-6 membered monocyclic heterocyclyl having 1-3 heteroatoms independently selected from N, O, and S, wherein the 4-6 membered monocyclic heterocyclyl is optionally substituted with 1-6 groups independently selected from —CN, —OH, halogen, oxo, C1-3 alkyl, and C1-3 alkoxy.